benzinga.com
Positivewww.benzinga.com ·
Cathie Wood Sells Amd Buys AI Stock
Nutritional ProgramsFood And In Kind TransfersTherapeuticSocial Assistance
Topic context
This topic has been covered 141488 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedCathie Wood's Ark Invest is rotating from diagnostics and biotech stocks into AI-focused Tempus AI, signaling a sector preference shift. The mechanism is portfolio reallocation by a high-profile fund manager, not a fundamental supply/demand change. Impact is limited to stock-specific sentiment and capital flows; no commodity or broad sector price effect is implied.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Ark Invest bought $7.8 million of Tempus AI stock.
- Tempus AI diagnostics revenue up 34.7%.
- Tempus AI data applications revenue up 40.5% to $87 million.
- Ark sold shares of CareDx, Adaptive Biotechnologies, and Teradyne.
- Ark bought 102,247 shares of Intellia Therapeutics.
